Cory J. Fox

Associate

Houston
T 713.646.1358  |  F 713.751.1717

Cory Fox focuses his practice on assisting clients in the healthcare industry, with an emphasis on issues related to privacy and data protection pursuant to the Health Insurance Portability and Accountability Act (HIPAA) and related state law. As a former research chemist, Cory leverages his prior experience working with academic medical centers, hospitals, pharmaceutical companies, and other healthcare organizations to efficiently assess a client's internal operations and provide the targeted advice and services necessary to address the wide variety of complex legal issues healthcare organizations face.

Cory is a regular contributor to the firm's Data Privacy Monitor and Health Law Update blogs.

Select Experience

  • Represented three large academic medical centers in data breach matters involving the theft of a laptop through all phases of breach response including crisis management, incident investigation, notification of affected individuals, and reporting to the U.S. Department of Health & Human Services (HHS) Office for Civil Rights (OCR) and state regulators. Assisted with subsequent OCR investigations by responding to requests for information regarding the breach incidents as well as each entity's overall HIPAA compliance. The investigations closed with no disciplinary action taken.
  • Advised large hospital system during OCR investigation regarding the hospital's provision of auxiliary aids and services to the hearing impaired under Section 504 of the Rehabilitation Act and the Americans with Disabilities Act. Investigation closed with no disciplinary action taken.
  • Advised multiple compounding pharmacies and an industry trade organization regarding FDA regulatory issues under the Drug Quality and Security Act, including facility registration, cGMP compliance, and the submission of comments and information pursuant to FDA regulatory proposals and guidance. 
More »

Experience

  • Represented three large academic medical centers in data breach matters involving the theft of a laptop through all phases of breach response including crisis management, incident investigation, notification of affected individuals, and reporting to the U.S. Department of Health & Human Services (HHS) Office for Civil Rights (OCR) and state regulators. Assisted with subsequent OCR investigations by responding to requests for information regarding the breach incidents as well as each entity's overall HIPAA compliance. The investigations closed with no disciplinary action taken.
  • Assisted two state chartered credit unions with data breach matters involving malware attacks by coordinating internal investigations regarding the incidents, preparing notification letters and regulatory filings in accordance with applicable state and federal laws, and providing legal support following breach notification.
  • Advised large hospital system during OCR investigation regarding the hospital's provision of auxiliary aids and services to the hearing impaired under Section 504 of the Rehabilitation Act and the Americans with Disabilities Act. Investigation closed with no disciplinary action taken.
  • Advised pain management clinic regarding drug diversion matter, including reporting of the incident to the Drug Enforcement Administration (DEA) and implementation of controlled substance recordkeeping policies and procedures. Assisted with subsequent DEA investigation and audit by responding to the DEA's requests for information regarding the diversion incident and the clinic's controlled substance records. No disciplinary action has been taken against the clinic.
  • Assisted two home health agencies with the development and implementation of comprehensive compliance programs addressing fraud and abuse prevention under the Stark Law and the Anti-Kickback statute, health information privacy under HIPAA and Texas law, and operational issues associated with regulations promulgated by the Texas Department of Aging and Disability Services.
  • Advises hospitals, academic medical centers, pharmacies, physicians, and business associates regarding development, implementation, and review of health information privacy policies and procedures pursuant to HIPAA and applicable state law. Assists these entities in periodically revising privacy policies and procedures in response to statutory and regulatory amendments and addresses operational questions related to privacy and safeguarding of patient information.
  • Advised multiple compounding pharmacies and an industry trade organization regarding FDA regulatory issues under the Drug Quality and Security Act, including facility registration, cGMP compliance, and the submission of comments and information pursuant to FDA regulatory proposals and guidance.

Recognitions

  • Certified Information and Privacy Professional (CIPP/US)

Memberships

  • American Health Lawyers Association
  • International Association of Privacy Professionals
  • Food and Drug Law Institute
  • American Bar Association
  • State Bar of Texas
  • Houston Bar Association

Alerts

Articles

Services

Industries

Prior Positions

  • U.S. Department of Health and Human Services Office of Counsel to the Inspector General: Summer Law Clerk (Summer 2011)
  • University of Texas Medical Branch: Law Clerk (2010 to 2012) 
  • MD Anderson Cancer Center Department of Pulmonary Medicine: Research Assistant (2009 to 2010)
  • BioAutomation: Research and Development Chemist (2007 to 2009)

Admissions

  • Texas, 2012

Education

  • J.D., University of Houston Law Center, 2012, National Order of Scribes; Chief Articles Editor, Houston Journal of Health Law & Policy; Moot Court
  • B.S., Biology and Chemistry, Texas Tech University, 2007, Beta Beta Beta Biological Honors Society

Blog

In The Blogs

Previous Next
Data Privacy Monitor
“Like It” or Not, Big Data Decisions Affect Business Valuations
March 23, 2015
Over the past decade, we have witnessed the emergence of data-driven enterprises, with business models built on the acquisition, use and sale of data. Included in that group are some of the most highly valued companies in the world, such...
Read More ->
Health Law Update
FDA Establishes Docket for Public Comments on Drug Compounding
March 19, 2015
The Food and Drug Administration (FDA) recently announced a new docket for public comments on the compounding of human drug products under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FFDCA). The FDA hopes that these...
Read More ->
Health Law Update
State Health Regulatory Bodies Have Teeth Pulled
March 17, 2015
Old and new regulations established by state professional boards that are composed of “active market participants” such as physicians, dentists and therapists, may be subject to antitrust challenge following the U.S. Supreme Court’s recent...
Read More ->
Health Law Update
My Day at the U.S. Supreme Court: King v. Burwell
March 13, 2015
Describing her recent Supreme Court experience as “my Super Bowl,” Susan Feigin Harris offers her personal account and analysis of the oral arguments in King v. Burwell. I was ready to go: hat, gloves, boots and parka. A legal pad and two...
Read More ->
Health Law Update
FDA Issues Draft Memorandum of Understanding for 503A Drug Compounding
March 10, 2015
Included in the flurry of guidance documents recently issued by the FDA concerning human drug compounding is a long-awaited document of great importance to mail-order pharmacy compounders and entities that rely on interstate distribution...
Read More ->